comparemela.com

Latest Breaking News On - Ka seng thomas - Page 1 : comparemela.com

Cognos Announces U.S. Patent Award for Cerebral Microdialysis

INGLEWOOD, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) Cognos Therapeutics, Inc. (“Cognos” or the “Company”), a medical technology company focused on developing implantable smart pump technology, today announced its U.S.

United-states
Cayman-islands
Japan
China
Australia
Mexico
Canada
Henry-monzon
Ka-seng-thomas
Frank-adell
Vivian-cervantes
Cogno-sinnais

Chardan Engaged to Facilitate Nocturne Acquisition

Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing

Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cayman-islands
Gilmartin-groupvivian-cervantes
Henry-monzon
Ka-seng-thomas
Cognos-therapeutics-inc
Cognos
Purpose-acquisition-company
Nocturne-acquisition-corp
Nocturne-acquisition-corporation
Nasdaq
Stock-exchange
Acquisition-corporation

Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing

Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cayman-islands
Ka-seng-thomas
Henry-monzon
Vivian-cervantes
Nocturne-acquisition-corporation
Nocturne-acquisition-corp
Stock-exchange
Nasdaq
Purpose-acquisition-company
Cognos
Gilmartin-group
Cognos-therapeutics-inc
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.